Document Top

  • E2100: Avastin plus paclitaxeldoubles PFS in 1L mBC

    E2100: pivotal trial of Avastin plus paclitaxel

        

     More

  • E2100: consistent PFS benefit across patient subgroups

    Avastin plus paclitaxel significantly increases PFS

       

     More

  • E2100: Avastin plus paclitaxelmore than doubles ORR

    Safety of Avastin: results from E2100

       

     

     More

  • E2100: Avastin has limited impact on side effects of paclitaxel

    E2100: effect of Avastin on QoL

       

     

     More

 
Case studies

Patient cases

Physicians share their experience and discuss  treatment options for patients with breast cancer.
The case presentations are designed to provide an insight into clinical practice and treatment decisions supported by trial data

More

LATEST PATIENT CASES

  • Angiogenesis, VEGF and the MoA of Avastin

    Angiogenesis, VEGF and the MoA of Avastin

    Precise VEGF inhibition with Avastin is a proven anti-tumour strategy

    View

  • Avastin controls tumour growth

    Avastin controls tumour growth

    Avastin efficacy data in multiple tumour types and combination therapy.

    View

  • Controlling angiogenesis to control tumour growth

    Controlling angiogenesis to control tumour growth

    Avastin precisely targets VEGF to inhibit angiogenesis for continuous tumour control

    View

Watch more

  • From tumour biology to biomarkers

    From tumour biology to biomarkers

    An insight into the evolving role of biomarkers for anti-angiogenesis therapy in oncology (Dr Donald McDonald)

    View

  • Clinical endpoints in oncology

    Clinical endpoints in oncology

    A discussion of clinical trial endpoints used in oncology trials and how these translate into patient benefit (Dr Artur Katz)

    View

Watch more

  • mBC patient case

    mBC patient case

    A patient with hormone receptor-positive aggressive breast cancer (Dr Sunil Verma)

    View

  • mBC patient case

    mBC patient case

    A patient with triple-negative breast cancer (Dr Thierry Petit)

    View

  • mBC patient case

    mBC patient case

    Triple-negative breast cancer patient with pre-existing controlled hypertension (Dr Paulo Cortes)

    View

Watch more

Upcoming Conferences

  • Austria
    EBCC
    ,
    Vienna, Austria
    21-24 March 2012
  • USA
    AACR
    ,
    Chicago, IL, USA
    31 March 2012 - 04 April 2012
  • Spain
    EONS
    ,
    Valencia, Spain
    26-27 April 2012

More upcoming conferences

x

You are now leaving the www.avastin.net website. Links to all external sites are provided as a resource to our visitors. Hoffmann-La Roche Inc. ("Roche") accepts no responsibility for the content of these sites. Roche does not control these sites, and the opinions, claims, or comments expressed on these sites should not be attributed to Roche, except where indicated. We recommend that you consult with your physician or other healthcare provider to obtain more information about any Roche prescription medication.

OK Cancel